A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...
We're honouring the big-screen stars, musical icons, footballers, and others who left a lasting impact on the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback